Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 5, Mai 2002
Page(s) 542 - 543
Section Le Magazine : Nouvelles
DOI http://dx.doi.org/10.1051/medsci/2002185542
Publié en ligne 15 mai 2002
  1. Wu H, Liu X, Jaenish R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83 : 59–67.
  2. Bergrem H, Danielson BG, Eckardt KU, Kurtz A, Strisberg M. A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In : Erythropoïetin: molecular physiology and clinical application. New York : Marcel Dekker, 1993 : 266–75.
  3. Peces R, de la Torre M, Alcazar R, Urra JM. Antibodies against recombinant human erythropoietin in a patient with ery-thropoietin-resistant anemia. N Engl J Med 1996; 335 : 524–5.
  4. Prabhakar S, Muhlfelder T. Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 1997; 47 : 331–5.
  5. Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002 346 : 469–75.
  6. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Spontaneous auto-antibody against erythropoietin in a case of pure red cell aplasia. N Engl J Med 1996; 334 : 630–3.